About DPB Pharmaceuticals Limited
Data last updated:
DPB Pharmaceuticals Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 20 April 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24304MH2018PLC308316. Its GSTIN is 27AAGCD6581N1Z0 (Maharashtra).
The company has an authorised share capital of ₹5.05 Cr and a paid-up capital of ₹3.13 Cr. It is led by directors including Devang Manharlal Ajmera and Piyush Manharlal Ajmera.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 308 3rd Floor Exim Link Indira Container Yard Nr.Nahur Railway Station Bhandup W, Mumbai, Maharashtra, India – 400078.
As per the financials filed for FY 2024, the company reported a revenue of ₹223.13 Cr, a growth of 18% compared to the previous year. For the same year it recorded a net profit of ₹12.31 Cr (net margin 5.5%) and EBITDA of ₹12.04 Cr (EBITDA margin 5.4%). Revenue has grown at a compounded annual rate (CAGR) of 51% over three years.
The company is associated with 2 brands: DPB Group and DPB Antibiotics. As per MCA filings, the company has open charges of ₹74 Cr and satisfied charges of ₹10 Cr on record. The company has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹3.08 Cr; the latest was in February 2023. Its 10 peer companies in the Pharma industry (Pharmaceuticals) are compared by revenue, 5 larger and 5 smaller; the largest is Rakshit Pharmaceuticals Limited with revenue of ₹238.14 Cr. The company has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 93 overdue payments to 25 micro and small suppliers.
For more details, the company can be reached via its website dpbpharma.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address308 3rd Floor Exim Link Indira Container Yard Nr.Nahur Railway Station Bhandup W, Mumbai, Maharashtra, India – 400078
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of DPB Pharmaceuticals Limited
The main business activity of DPB Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of DPB Pharmaceuticals Limited FY 2024 filings available
DPB Pharmaceuticals Limited reported revenue of ₹223.13 Cr (up 18% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of DPB Pharmaceuticals Limited
Revenue has grown at a compounded annual rate (CAGR) of 51% over three years, including 18% growth in the latest year. EBITDA fell 29% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of DPB Pharmaceuticals Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹12.04 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹12.31 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of DPB Pharmaceuticals Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 5.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of DPB Pharmaceuticals are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of DPB Pharmaceuticals Limited
DPB Pharmaceuticals Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Rakshit Pharmaceuticals Limited | ₹238.14 Cr (FY 2024) | •••• | •••• | -6.0% | •••• | Hyderabad, Telangana, India |
| Century Pharmaceuticals Limited | ₹234.99 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Vadodara, Gujarat, India |
| Ferring Pharmaceuticals Private Limited | ₹233.5 Cr (FY 2024) | •••• | •••• | 7.0% | •••• | Mumbai, Maharashtra, India |
| Dosch Pharmaceuticals Private Limited | ₹229.86 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Mumbai, Maharashtra, India |
| Aura Pharmaceuticals Private Limited | ₹223.55 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Mumbai, Maharashtra, India |
| DPB Pharmaceuticals Limited this company | ₹223.13 Cr (FY 2024) | •••• | •••• | 18.0% | •••• | Mumbai, Maharashtra, India |
| Nestor Pharmaceuticals Limited | ₹222.19 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | New Delhi, Delhi, India |
| Concept Pharmaceuticals Limited | ₹222.11 Cr (FY 2024) | •••• | •••• | -29.0% | •••• | Mumbai, Maharashtra, India |
| Relax Pharmaceuticals Private Limited | ₹215.76 Cr (FY 2024) | •••• | •••• | 29.0% | •••• | Saharanpur, Uttar Pradesh, India |
| Brinton Pharmaceuticals Limited | ₹215.48 Cr (FY 2025) | •••• | •••• | 15.0% | •••• | Pune, Maharashtra, India |
| Supermax Drugs & Pharmaceuticals Private Limited | ₹214.07 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below DPB Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of DPB Pharmaceuticals Limited
DPB Pharmaceuticals Limited is audited by JAYSHREE JAIN & CO. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| JAYSHREE JAIN & CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of DPB Pharmaceuticals Limited
DPB Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Devang Manharlal Ajmera | Director | 20 Apr 2018 | 8 Years 5 Months | Current |
| Piyush Manharlal Ajmera Also directs: Vardhman Chemtech Limited, DPB Antibiotics Private Limited | Director | 20 Apr 2018 | 8 Years 5 Months | Current |
| Bhavin Manharlal Ajmera Also directs: Vardhman Chemtech Limited, DPB Antibiotics Private Limited | Director | 20 Apr 2018 | 8 Years 5 Months | Current |
Ownership and Shareholding of DPB Pharmaceuticals Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of DPB Pharmaceuticals Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Apr 2025 | Others | ₹24 Cr | Open |
| 26 Mar 2024 | Yes Bank Limited | ₹20 Cr | Open |
| 24 Jun 2022 | Others | ₹20 Cr | Open |
| 26 Apr 2022 | The Hongkong and Shanghai Banking Corporation Limited | ₹10 Cr | Open |
| 19 Aug 2022 | Hdfc Bank Limited | ₹10 Cr | Satisfied |
Total charge records: 5 View all charges
Deals & Funding of DPB Pharmaceuticals Limited
DPB Pharmaceuticals Limited has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹3.08 Cr; the latest was in February 2023.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Feb 2023 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
| Oct 2021 | Funding round | ₹3.08 Cr | Investors: 3 individuals |
Full deal history
All 2 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
MSME Payment Delays by DPB Pharmaceuticals Limited
DPB Pharmaceuticals Limited has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 93 overdue payments to 25 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 25)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Emcure Pharmaceuticals Limited | •••• | •••• | •••• |
| Cohance Lifesciences Limited | •••• | •••• | •••• |
| Ipca Laboratories Limited | •••• | •••• | •••• |
| Sun Pharmaceutical Industries Limited | •••• | •••• | •••• |
| Aarti Pharmalabs Limited | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 1 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with DPB Pharmaceuticals Limited
DPB Pharmaceuticals operates two associated brands: DPB Group and DPB Antibiotics. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| DPB Group is engaged in manufacturing pharmaceutical APIs in India. | dpbpharma.com | |
| Specializes in the manufacturing and supplying of active pharmaceutical ingredients (APIs). | dpbantibiotics.com |
Employees and EPFO Compliance at DPB Pharmaceuticals Limited
Employment history and EPFO contributions of people linked to DPB Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of DPB Pharmaceuticals Limited
DPB Pharmaceuticals has 2 associated companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
Recent Activity on DPB Pharmaceuticals Limited
DPB Pharmaceuticals Limited has 3 board changes on record since 2018: 3 appointments. The latest: Bhavin Manharlal Ajmera was appointed as Director on 20 Apr 2018.
1 earlier event is listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for DPB Pharmaceuticals Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of DPB Pharmaceuticals Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of DPB Pharmaceuticals Limited
DPB Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCD6581N1Z0 | Maharashtra | Active | 21 Sep 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of DPB Pharmaceuticals Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DPB Pharmaceuticals Limited
DPB Pharmaceuticals is an active public limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 20 April 2018 (8+ years old) and is registered under CIN U24304MH2018PLC308316.
DPB Pharmaceuticals reported revenue of ₹223.13 Cr for FY 2024 (up 18% YoY).
DPB Pharmaceuticals has 3 current directors:
- Devang Manharlal Ajmera - Director
- Piyush Manharlal Ajmera - Director
- Bhavin Manharlal Ajmera - Director
DPB Pharmaceuticals reported a net profit of ₹12.31 Cr (net margin 5.5%) and EBITDA of ₹12.04 Cr (EBITDA margin 5.4%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of DPB Pharmaceuticals is 51% over three years. In the latest year (FY 2024) revenue rose 18%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of DPB Pharmaceuticals is 27AAGCD6581N1Z0, registered in Maharashtra.
The CIN (Corporate Identification Number) of DPB Pharmaceuticals is U24304MH2018PLC308316. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
DPB Pharmaceuticals was incorporated on 20 April 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
DPB Pharmaceuticals has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹3.08 Cr; the latest was in February 2023.
The peers of DPB Pharmaceuticals by revenue are Rakshit Pharmaceuticals Limited, Century Pharmaceuticals Limited, Ferring Pharmaceuticals Private Limited, Dosch Pharmaceuticals Private Limited, Aura Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Bhavin Manharlal Ajmera was appointed as Director on 20 Apr 2018. Devang Manharlal Ajmera was appointed as Director on 20 Apr 2018. Piyush Manharlal Ajmera was appointed as Director on 20 Apr 2018.
DPB Pharmaceuticals has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 93 overdue payments to 25 micro and small suppliers. The latest return was filed on 26 Apr 2024.